167 related articles for article (PubMed ID: 26066407)
1. Next-generation sequencing for molecular diagnosis of lung adenocarcinoma specimens obtained by fine needle aspiration cytology.
Qiu T; Guo H; Zhao H; Wang L; Zhang Z
Sci Rep; 2015 Jun; 5():11317. PubMed ID: 26066407
[TBL] [Abstract][Full Text] [Related]
2. Cytomorphological identification of advanced pulmonary adenocarcinoma harboring KRAS mutation in lymph node fine-needle aspiration specimens: Comparative investigation of adenocarcinoma with KRAS and EGFR mutations.
Song DH; Lee B; Shin Y; Choi IH; Ha SY; Lee JJ; Hong ME; Choi YL; Han J; Um SW
Diagn Cytopathol; 2015 Jul; 43(7):539-44. PubMed ID: 25427298
[TBL] [Abstract][Full Text] [Related]
3. Next-generation sequencing of liquid-based cytology non-small cell lung cancer samples.
Reynolds JP; Zhou Y; Jakubowski MA; Wang Z; Brainard JA; Klein RD; Farver CF; Almeida FA; Cheng YW
Cancer Cytopathol; 2017 Mar; 125(3):178-187. PubMed ID: 28085233
[TBL] [Abstract][Full Text] [Related]
4. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Graham RP; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
Oncotarget; 2016 Aug; 7(34):54526-54536. PubMed ID: 27203738
[TBL] [Abstract][Full Text] [Related]
5. Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel.
Scarpa A; Sikora K; Fassan M; Rachiglio AM; Cappellesso R; Antonello D; Amato E; Mafficini A; Lambiase M; Esposito C; Bria E; Simonato F; Scardoni M; Turri G; Chilosi M; Tortora G; Fassina A; Normanno N
PLoS One; 2013; 8(11):e80478. PubMed ID: 24236184
[TBL] [Abstract][Full Text] [Related]
6. Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung.
Karnes HE; Duncavage EJ; Bernadt CT
Cancer Cytopathol; 2014 Feb; 122(2):104-13. PubMed ID: 24227699
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis in cytological specimens of advanced lung adenocarcinoma: a sensitive method for molecular diagnosis.
Boldrini L; Gisfredi S; Ursino S; Camacci T; Baldini E; Melfi F; Fontanini G
J Thorac Oncol; 2007 Dec; 2(12):1086-90. PubMed ID: 18090579
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of next-generation sequencing for the identification of clinically relevant variants in cytology smears in lung adenocarcinoma.
Baum JE; Zhang P; Hoda RS; Geraghty B; Rennert H; Narula N; Fernandes HD
Cancer Cytopathol; 2017 Jun; 125(6):398-406. PubMed ID: 28272845
[TBL] [Abstract][Full Text] [Related]
9. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.
Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS
Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923
[TBL] [Abstract][Full Text] [Related]
10. Molecular testing in metastatic colorectal adenocarcinoma cytology cell pellets.
McHugh KE; Dermawan JK; Cheng YW; Cruise M; Sohal DPS; Reynolds JP
Diagn Cytopathol; 2019 Nov; 47(11):1132-1137. PubMed ID: 31290252
[TBL] [Abstract][Full Text] [Related]
11. Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics.
Kanagal-Shamanna R; Portier BP; Singh RR; Routbort MJ; Aldape KD; Handal BA; Rahimi H; Reddy NG; Barkoh BA; Mishra BM; Paladugu AV; Manekia JH; Kalhor N; Chowdhuri SR; Staerkel GA; Medeiros LJ; Luthra R; Patel KP
Mod Pathol; 2014 Feb; 27(2):314-27. PubMed ID: 23907151
[TBL] [Abstract][Full Text] [Related]
12. EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.
Schmid K; Oehl N; Wrba F; Pirker R; Pirker C; Filipits M
Clin Cancer Res; 2009 Jul; 15(14):4554-60. PubMed ID: 19584155
[TBL] [Abstract][Full Text] [Related]
13. Use of Exfoliative Specimens and Fine-Needle Aspiration Smears for Mutation Testing in Lung Adenocarcinoma.
Jain D; Ramachandrappa VS; Singh V; Malik PS; Madan K; Faruq M; Guleria R
Acta Cytol; 2017; 61(6):455-461. PubMed ID: 28848083
[TBL] [Abstract][Full Text] [Related]
14. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
Velizheva NP; Rechsteiner MP; Wong CE; Zhong Q; Rössle M; Bode B; Moch H; Soltermann A; Wild PJ; Tischler V
Cancer Cytopathol; 2017 Jan; 125(1):30-40. PubMed ID: 27636102
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer adrenal gland metastasis: Optimal fine-needle aspirate and touch preparation smear cellularity characteristics for successful theranostic next-generation sequencing.
Gleeson FC; Kipp BR; Levy MJ; Voss JS; Campion MB; Minot DM; Tu ZJ; Klee EW; Lazaridis KN; Kerr SE
Cancer Cytopathol; 2014 Nov; 122(11):822-32. PubMed ID: 25045116
[TBL] [Abstract][Full Text] [Related]
16. Kinase genotype analysis of gastric gastrointestinal stromal tumor cytology samples using targeted next-generation sequencing.
Gleeson FC; Kipp BR; Kerr SE; Voss JS; Graham RP; Campion MB; Minot DM; Tu ZJ; Klee EW; Lazaridis KN; Henry MR; Levy MJ
Clin Gastroenterol Hepatol; 2015 Jan; 13(1):202-6. PubMed ID: 24997326
[TBL] [Abstract][Full Text] [Related]
17. Somatic STK11 and concomitant STK11/KRAS mutational frequency in stage IV lung adenocarcinoma adrenal metastases.
Gleeson FC; Kipp BR; Levy MJ; Voss JS; Campion MB; Minot DM; Tu ZJ; Klee EW; Lazaridis KN; Kerr SE
J Thorac Oncol; 2015 Mar; 10(3):531-4. PubMed ID: 25695224
[TBL] [Abstract][Full Text] [Related]
18. Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma.
Yip PY; Yu B; Cooper WA; Selinger CI; Ng CC; Kennedy CW; Kohonen-Corish MR; McCaughan BC; Trent RJ; Boyer MJ; Kench JG; Horvath LG; O'Toole SA
J Thorac Oncol; 2013 Apr; 8(4):408-14. PubMed ID: 23392229
[TBL] [Abstract][Full Text] [Related]
19. Using "residual" FNA rinse and body fluid specimens for next-generation sequencing: An institutional experience.
Wei S; Lieberman D; Morrissette JJ; Baloch ZW; Roth DB; McGrath C
Cancer Cytopathol; 2016 May; 124(5):324-9. PubMed ID: 26682952
[TBL] [Abstract][Full Text] [Related]
20. Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several Cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge.
Pelosi G; Fabbri A; Papotti M; Rossi G; Cavazza A; Righi L; Tamborini E; Perrone F; Settanni G; Busico A; Testi MA; Maisonneuve P; De Braud F; Garassino M; Valeri B; Sonzogni A; Pastorino U
J Thorac Oncol; 2015 Nov; 10(11):1560-9. PubMed ID: 26317919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]